CSIMarket
 
Labcorp Holdings Inc   (NYSE: LH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $228.3100 $-0.27 -0.118%
Day's High: $229.24 Week Perf: 7.52 %
Day's Low: $ 226.50 30 Day Perf: -2.16 %
Volume (M): 907 52 Wk High: $ 258.59
Volume (M$): $ 207,146 52 Wk Avg: $225.08
Open: $228.03 52 Wk Low: $191.97



 Market Capitalization (Millions $) 19,267
 Shares Outstanding (Millions) 84
 Employees 70,000
 Revenues (TTM) (Millions $) 13,009
 Net Income (TTM) (Millions $) 747
 Cash Flow (TTM) (Millions $) 982
 Capital Exp. (TTM) (Millions $) 490

Labcorp Holdings Inc
Company Profile: Labcorp Holdings Inc.

Overview:
Labcorp Holdings Inc. headquartered in Burlington, North Carolina, stands as the second largest independent clinical laboratory company in the United States. The company operates a national network of laboratories offering more than 4,400 clinical laboratory tests, integral to routine testing, patient diagnosis, and monitoring and treating diseases.

Services Offered:
Labcorp provides an extensive range of laboratory services which include:

- Clinical Testing: Routine laboratory tests performed on blood, urine, and other body fluids, as well as anatomical pathology testing.
- Specialized Testing: Services include oncology testing, HIV genotyping and phenotyping, diagnostic genetics, and participation in clinical research trials.
- Genomic and Advanced Testing: Leading the market in genomic testing technologies, with a strong focus on infectious diseases and cancer diagnostics.

Acquisitions:
To expand its testing capabilities, Labcorp has acquired several companies, including Dynacare Inc. and DIANON Systems, enhancing its specialty and niche businesses.

Operations:
Labcorp operates 31 primary testing facilities and over 1,200 service sites, including branches, patient service centers, and STAT laboratories. The companys in-house courier system ensures efficient specimen transport to its laboratories for testing.

Compliance and Ethics:
Labcorp is committed to maintaining the highest quality standards in laboratory services, adhering to all relevant federal, state, and local laws. The company has a stringent Code of Business Conduct and Ethics applicable to all employees and board members.

Industry Context:
The clinical laboratory testing market is vital for healthcare providers, assisting in diagnosing, evaluating, and monitoring patients health. Labcorp competes primarily with hospital-based laboratories and other independent clinical laboratories, such as Quest Diagnostics.

Client Base:
Labcorp serves a diverse clientele, including independent physicians, hospitals, HMOs, and managed care organizations, as well as governmental agencies and large employers. The company typically bills for services on a fee-for-service basis, with negotiations based on customer fee schedules.

Strategic Objectives:
Labcorp aims to grow its leadership in genomic and advanced testing technologies while broadening its testing services through continued research, development, and selective acquisitions. The company strives to develop and bring to market innovative testing technologies, enhancing patient and physician experiences.

Conclusion:
Labcorp Holdings Inc. is a prominent player in the clinical laboratory industry, poised for continued growth through innovation and strategic expansions in testing capabilities, supporting healthcare providers in delivering exceptional patient care.


   Company Address: 358 South Main Street Burlington 27215 NC
   Company Phone Number: 229-1127   Stock Exchange / Ticker: NYSE LH


Customers Net Income fell by LH's Customers Net Profit Margin fell to

-17.94 %

1.24 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DGX        7.27% 
HOLX        7.27% 
IQV        6.42% 
NOTV        6.42% 
RDNT        6.91% 
XGN        6.91% 
• View Complete Report
   



Labcorp Holdings Inc

Labcorp Holdings Inc. Achieves Impressive Revenue and Earnings Growth in Q2 2024

Labcorp Holdings Inc. recently announced a solid performance for the period from April to June 30, 2024. The company experienced a 6.171% growth in revenue, reaching $3.22 billion compared to $3.03 billion in the previous year. Additionally, Labcorp posted earnings growth of 14.62%, with earnings per share (EPS) increasing to $2.43 from $2.12 in the prior year financial reporting period. However, while revenue grew by 1.395% from the preceding period, EPS declined by -9.67%, from $2.69 per share.
Labcorp Holdings Inc. also emphasized its improving profit margins, with the net margin rising to 6.38% in the second quarter of 2024 earnings season, and the operating margin increasing to 9.15%. Furthermore, operating earnings grew by 10.7%, reaching $294.8 million.

Stocks on the Move

Advancements in Personalized Medicine Drive Expansion of Esoteric Testing Market Global Size to Surpass $73 Billion b...

Published Wed, Jun 26 2024 2:45 PM UTC

In recent years, significant advancements in personalized medicine and the growing demand for specialized diagnostics have propelled the expansion of the esoteric testing market. As clinical research organizations (CROs) play a crucial role in improving efficiency during the drug development process, their ranking and performance have become a key consideration for pharmaceu...

Laboratory Corporation Of America Holdings

LabCorp's Profitability Soars with 12.55% Income Growth in Q1 2024

The recent financial results of Laboratory Corporation Of America Holdings paint a bleak picture for the company's future prospects. While earnings per share saw a modest increase, the significant decline in revenue is concerning. The company's revenue has dropped by almost 16% compared to the previous year, showcasing a clear lack of growth and profitability. This decline is also in stark contrast to the rest of the Medical Laboratories sector, which has seen an overall increase in revenue.
Furthermore, Laboratory Corporation Of America Holdings' operating earnings fell by over 5%, leading to a decrease in operating margin. This indicates that the company is facing challenges in maintaining its profitability and efficiency. Despite efforts to improve profit margins, the overall financial performance of the company remains lackluster.

Products & Services

Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw

Published Mon, Apr 15 2024 11:00 AM UTC

Labcorp Introduces Groundbreaking Blood Test for Early Detection of Neurodegenerative Diseases and Brain InjuriesLabcorp, a renowned leader in innovative diagnostic testing, has recently announced the launch of a groundbreaking blood test that can provide early indications of neurodegenerative diseases and brain injuries. This cutting-edge test utilizes a blood draw to measu...

Dividend

Labcorp's Quarterly Dividend Announcement Spurs Investor Interest, Yet Potential for Increased Returns Remains

Published Thu, Apr 11 2024 10:59 AM UTC

Labcorp Declares Quarterly Dividend and Assesses Impact on Company Shares
Labcorp, a renowned leader in innovative laboratory services, recently announced that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. This news has generated considerable interest in the investor community, as they assess the potential impact on the company ...







Labcorp Holdings Inc's Segments
InterEliminations    0.28 % of total Revenue
Diagnostics    77.8 % of total Revenue
Drug Development    22.48 % of total Revenue
UNITED STATES    83.44 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com